Process for removing mercury ions from bodily fluids using titanium metallate ion exchange compositions

Patent metadata

Field	Value
Publication number	US-11484875-B2
Application number	US-201916506419-A
Country	US
Kind code	B2
Filing date	Jul 9, 2019
Priority date	Jul 9, 2019
Publication date	Nov 1, 2022
Grant date	Nov 1, 2022

Abstract

A process for removing Hg 2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula:

A m TiNb a Si x O y .

A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.

First claim

We claim as our invention:

1. A process for removing Hg 2+ toxins from bodily fluids selected from the group consisting of blood, gastrointestinal fluids and dialysate solution comprising contacting the fluid containing the toxins with an ion exchanger at ion exchange conditions thereby removing at least 95% of the Hg 2+ from the fluid, the ion exchanger selected from the group consisting of a titanium metallates, the metallates respectively having an empirical formula on an anhydrous basis of:
A m TiNb a Si x O y

where A is an exchangeable cation selected from the group consisting of potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, “m” is the mole ratio of A to Ti and has a value from 0.10 to 3, “a” is the mole ratio of Nb to Ti and has a value from zero to 0.60, “x” is the mole ratio of Si to Ti has a value from 0 to 3, and “y” has a value from 2.05 to 11 and wherein said titanium metallate has a topology selected from the group consisting of sodium nonatitanate, sitinakite, acid treated zorite and mixtures thereof.

2. The process of claim 1 wherein the bodily fluid is selected from the group consisting of whole blood, blood plasma, or other component of blood, gastrointestinal fluids and dialysate solution containing blood, blood plasma, other component of blood or gastrointestinal fluids.

3. The process of claim 1 where a=0 and the ion exchanger is titanium silicate with the sitinakite topology or acid treated titanium silicate with the sitinakite topology.

4. The process of claim 1 where a>0 and the ion exchanger is titanium niobium silicate with the sitinakite topology or acid treated titanium niobium silicate with the sitinakite topology.

5. The process of claim 1 where a=0 and the ion exchanger is acid treated titanium silicate with the zorite topology.

6. The process of claim 1 where a>0 and the ion exchanger is acid treated titanium niobium silicate with the zorite topology.

7. The process of claim 1 where x=0, a=0 and the ion exchanger is a titanium oxide with the sodium nonatitanate topology.

8. The process of claim 1 where x=0, a>0, and the ion exchanger is a titanium niobium oxide with the sodium nonatitanate topology.

9. The process of claim 1 where A is sodium, calcium, magnesium, hydronium ion or mixtures thereof.

10. The process of claim 1 wherein the ion exchanger is packed into hollow fibers incorporated into a membrane.

11. The process of claim 1 wherein said process is a hemoperfusion process wherein said bodily fluid is sent through a column containing said ion exchanger.

12. The process of claim 1 wherein said ion exchanger regenerates a dialysate solution.

13. The process of claim 1 wherein a dialysate solution is introduced into a peritoneal cavity and then is flowed through at least one adsorbent bed containing at least one of said ion exchanger.

14. The process of claim 1 wherein said ion exchanger is formed into a shaped article to be ingested orally and to pick up said toxins from a gastrointestinal fluid in a mammal's intestines followed by excretion of said shaped article containing said toxins.

15. The process of claim 14 wherein said shaped article is coated with a coating that is not dissolved by conditions within a stomach.

16. The process of claim 1 wherein said process is continuous ambulatory peritoneal dialysis or automated peritoneal dialysis.

17. A composition for removing at least 95% of Hg 2+ toxins from bodily fluids selected from the group consisting of blood, gastrointestinal fluids and dialysate solution, the composition comprising an ion exchanger selected from the group consisting of a titanium metallates, the metallates respectively having an empirical formula on an anhydrous basis of:
A m TiNb a Si x O y

where A is an exchangeable cation selected from the group consisting of potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, “m” is the mole ratio of A to Ti and has a value from 0.10 to 3, “a” is the mole ratio of Nb to Ti and has a value from zero to 0.60, “x” is the mole ratio of Si to Ti has a value from 0 to 3, and “y” has a value from 2.05 to 11 and wherein said titanium metallate has a topology selected from the group consisting of sodium nonatitanate, sitinakite, acid treated zorite and mixtures thereof.

18. An apparatus for removing at least 95% of Hg 2+ toxins from bodily fluids from the group consisting of blood, gastrointestinal fluids and dialysate solution, the apparatus comprising an ion exchanger selected from the group consisting of a titanium metallates, the metallates respectively having an empirical formula on an anhydrous basis of:
A m TiNb a Si x O y

where A is an exchangeable cation selected from the group consisting of potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, “m” is the mole ratio of A to Ti and has a value from 0.10 to 3, “a” is the mole ratio of Nb to Ti and has a value from zero to 0.60, “x” is the mole ratio of Si to Ti has a value from 0 to 3, and “y” has a value from 2.05 to 11 and wherein said titanium metallate has a topology selected from the group consisting of sodium nonatitanate, sitinakite, acid treated zorite and mixtures thereof; and
a matrix containing a support material for said ion exchanger.

19. The apparatus of claim 18 wherein said matrix comprises a porous network comprising biocompatible polymers and metal oxides and silicates.

20. The apparatus of claim 19 wherein said biocompatible polymers comprise cross-linked carbohydrates or proteins.

Assignees

• Uop Llc

Inventors

• Lewis Gregory John
• Jakubczak Paulina
• Marte Julio C
• Sheets William Christopher

Classifications

• B01D15/362

  Cation-exchange · CPC title

• B01J39/02 Primary

  Processes using inorganic exchangers · CPC title

• A61M1/28

  Peritoneal dialysis {; Other peritoneal treatment, e.g. oxygenation} · CPC title

• A61M1/1678

  intracorporal (peritoneal dialysis A61M1/28) · CPC title

• A61M1/3486

  Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents · CPC title